G. C. Burdge, Metabolism of ??-linolenic acid in humans, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.75, issue.3, pp.161-168, 2006.
DOI : 10.1016/j.plefa.2006.05.013

E. N. Siguel, K. M. Chee, J. X. Gong, and E. J. Schaefer, Criteria for essential fatty acid deficiency in plasma as assessed by capillary column gas-liquid chromatography, Clin. Chem, vol.33, pp.1869-1873, 1987.

J. P. Kurvinen, A. Kuksis, A. J. Sinclair, L. Abedin, and H. Kallio, The effect of low ??-linolenic acid diet on glycerophospholipid molecular species in guinea pig brain, Lipids, vol.60, issue.Suppl. 1, pp.1001-1009, 2000.
DOI : 10.1007/s11745-000-0611-1

. Desaturation-of-docosatetraenoate, 4(n-6)) and docosapentaenoate (22:5(n-3)) by human cells in culture, Biochim. Biophys. Acta, vol.22, issue.1083, pp.29-36, 1991.

N. E. Furland, E. N. Maldonado, and M. I. Aveldaño, Very long chain PUFA in murine testicular triglycerides and cholesterol esters, Lipids, vol.268, issue.1, pp.73-80, 2003.
DOI : 10.1007/s11745-003-1033-9

O. Berdeaux, P. Juaneda, L. Martine, S. Cabaret, L. Bretillon et al., Identification and quantification of phosphatidylcholines containing very-long-chain polyunsaturated fatty acid in bovine and human retina using liquid chromatography/tandem mass spectrometry, Journal of Chromatography A, vol.1217, issue.49, pp.7738-7748, 2010.
DOI : 10.1016/j.chroma.2010.10.039

URL : https://hal.archives-ouvertes.fr/hal-01137063

L. R. Mclean, S. Best, A. Balasubramaniam, and R. L. Jackson, Fatty acyl chain specificity of phosphatidylcholine hydrolysis catalyzed by lipoprotein lipase. Effect of apolipoprotein C-II and its (56???79) synthetic fragment, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.878, issue.3, pp.446-449, 1986.
DOI : 10.1016/0005-2760(86)90255-9

R. J. Mayer and L. A. Marshall, New insights on mammalian phospholipase A2(s); comparison of arachidonoyl-selective and -nonselective enzymes, FASEB J. Review, vol.7, pp.339-348, 1993.

K. S. Authi, M. Lagarde, and N. Crawford, Diacylglycerol lipase activity in human platelet intracellular and surface membranes, FEBS Letters, vol.222, issue.1, pp.95-101, 1985.
DOI : 10.1016/0014-5793(85)80239-8

D. N. Brindley and D. W. Waggoner, Phosphatidate phosphohydrolase and signal transduction, Chemistry and Physics of Lipids, vol.80, issue.1-2
DOI : 10.1016/0009-3084(96)02545-5

A. A. Farooqui, L. A. Horrocks, and T. Farooqui, Deacylation and Reacylation of Neural Membrane Glycerophospholipids: A Matter of Life and Death, Journal of Molecular Neuroscience, vol.14, issue.3, pp.123-135, 2000.
DOI : 10.1385/JMN:14:3:123

D. Portilla, S. V. Shah, P. A. Lehman, and M. H. Creer, Role of cytosolic calcium-independent plasmalogen-selective phospholipase A2 in hypoxic injury to rabbit proximal tubules., Journal of Clinical Investigation, vol.93, issue.4, pp.1609-1615, 1994.
DOI : 10.1172/JCI117141

S. M. Prescott, G. A. Zimmerman, D. M. Stafforini, and T. M. Mcintyre, Platelet-Activating Factor and Related Lipid Mediators, Annual Review of Biochemistry, vol.69, issue.1, pp.419-445, 2000.
DOI : 10.1146/annurev.biochem.69.1.419

F. Bussolino and G. Camussi, Platelet-Activating Factor Produced by Endothelial Cells. A Molecule with Autocrine and Paracrine Properties, European Journal of Biochemistry, vol.266, issue.2, pp.327-337, 1995.
DOI : 10.1083/jcb.110.2.529

M. Hamberg and . B. Samuelsson, Prostaglandin Endoperoxides. Novel Transformations of Arachidonic Acid in Human Platelets, Proceedings of the National Academy of Sciences, vol.71, issue.9, pp.3400-3404, 1974.
DOI : 10.1073/pnas.71.9.3400

B. Samuelsson, G. Folco, E. Granström, H. Kindahl, and C. Malmsten, Prostaglandins and thromboxanes: biochemical and physiological considerations, Adv. Prostaglandin Thromboxane Res Review, vol.4, pp.1-25, 1978.

S. Moncada and J. R. Vane, Prostacyclin in the cardiovascular system, Adv. Prostaglandin Thromboxane Res Review, vol.6, pp.43-60, 1980.

T. Hirabayashi and T. Shimizu, Localization and regulation of cytosolic phospholipase A(2) Biochim

J. F. Glatz, T. Börchers, F. Spener, and G. J. Van-der-vusse, Fatty acids in cell signalling: Modulation by lipid binding proteins, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.52, issue.2-3, pp.121-127, 1995.
DOI : 10.1016/0952-3278(95)90010-1

A. Hornych, M. Safar, N. Papanicolaou, P. Meyer, and P. Milliez, in Hypertensive Patients, European Journal of Clinical Investigation, vol.18, issue.5, pp.391-398, 1973.
DOI : 10.1172/JCI101618

H. Giles and P. Leff, The biology and pharmacology of PGD2, Prostaglandins, vol.35, issue.2, pp.277-300, 1988.
DOI : 10.1016/0090-6980(88)90093-7

Y. Kikuchi, T. Kita, J. Hirata, E. Kuki, I. Nagata et al., Modulation of human lymphocyte response to phytohemagglutinin by antineoplastic prostaglandins, Int. J

S. A. Kliewer, J. M. Lenhard, T. M. Willson, I. Patel, D. C. Morris et al., A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor ?? and promotes adipocyte differentiation, Cell, vol.83, issue.5, pp.813-819, 1995.
DOI : 10.1016/0092-8674(95)90194-9

H. H. Tai, H. Cho, M. Tong, and Y. Ding, NAD+-Linked 15-Hydroxyprostaglandin Dehydrogenase: Structure and Biological Functions, Current Pharmaceutical Design, vol.12, issue.8, pp.955-962, 2006.
DOI : 10.2174/138161206776055958

H. S. Hansen, Purification and characterization of a 15-ketoprostaglandin ??13-reductase from bovine lung, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.574, issue.1, pp.136-145, 1979.
DOI : 10.1016/0005-2760(79)90092-4

U. Diczfalusy and S. E. Alexson, Identification of metabolites from peroxisomal beta-oxidation of prostaglandins, J. Lipid Res, vol.31, pp.307-314, 1990.

M. E. Hemler and W. E. Lands, Evidence for a peroxide-initiated free radical mechanism of prostaglandin biosynthesis, J. Biol. Chem, vol.255, pp.6253-6261, 1980.

M. Hecker, M. Haurand, V. Ullrich, U. Diczfalusy, and S. Hammarström, Products, kinetics, and substrate specificity of homogeneous thromboxane synthase from human platelets: Development of a novel enzyme assay, Archives of Biochemistry and Biophysics, vol.254, issue.1, pp.124-135, 1987.
DOI : 10.1016/0003-9861(87)90088-9

M. Hamberg, J. Svensson, and B. Samuelsson, Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides., Proceedings of the National Academy of Sciences, vol.72, issue.8, pp.2994-2998, 1975.
DOI : 10.1073/pnas.72.8.2994

N. Whittaker, S. Bunting, J. Salmon, S. Moncada, J. R. Vane et al., The chemical structure of prostaglandin X (prostacyclin), Prostaglandins, vol.12, pp.915-928, 1976.

F. Ursini and A. Bindoli, The role of selenium peroxidases in the protection against oxidative damage of membranes, Chemistry and Physics of Lipids, vol.44, issue.2-4, pp.255-276, 1987.
DOI : 10.1016/0009-3084(87)90053-3

S. Bacot, N. Bernoud-hubac, N. Baddas, B. Chantegrel, C. Deshayes et al., Covalent binding of hydroxy-alkenals 4-HDDE, 4-HHE, and 4-HNE to ethanolamine phospholipid subclasses, The Journal of Lipid Research, vol.44, issue.5, pp.917-926, 2003.
DOI : 10.1194/jlr.M200450-JLR200

L. Coulon, C. Calzada, P. Moulin, E. Véricel, and M. Lagarde, Activation of P38 mitogen-activated protein kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets, Free Radical Biology and Medicine, vol.35, issue.6
DOI : 10.1016/S0891-5849(03)00386-1

M. I. Siegel, R. T. Mcconnell, S. L. Abrahams, N. A. Porter, and P. Cuatrecasas, Regulation of arachidonate metabolism via lipoxygenase and cyclo-oxygenase by 12-HPETE, the product of human platelet lipoxygenase, Biochemical and Biophysical Research Communications, vol.89, issue.4, pp.1273-1280, 1979.
DOI : 10.1016/0006-291X(79)92146-6

M. E. Hemler, H. W. Cook, and W. E. Lands, Prostaglandin biosynthesis can be triggered by lipid peroxides, Archives of Biochemistry and Biophysics, vol.193, issue.2, pp.340-345, 1979.
DOI : 10.1016/0003-9861(79)90038-9

C. Calzada, E. Vericel, and M. Lagarde, Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation, Biochemical Journal, vol.325, issue.2, pp.495-500, 1997.
DOI : 10.1042/bj3250495

E. I. Solomon, J. Zhou, F. Neese, and E. G. Pavel, New insights from spectroscopy into the structure/function relationships of lipoxygenases, Chemistry & Biology, vol.4, issue.11, pp.795-808, 1997.
DOI : 10.1016/S1074-5521(97)90113-7

B. Samuelsson and C. D. Funk, Enzymes involved in the biosynthesis of leukotriene B4, J. Biol

M. A. Bray, Leukotriene B4: an inflammatory mediator with vascular actions in vivo, Agents Actions, vol.11, pp.51-61, 1982.

S. Hammarström and . Leukotrienes, Leukotrienes, Annual Review of Biochemistry, vol.52, issue.1, pp.355-377, 1983.
DOI : 10.1146/annurev.bi.52.070183.002035

P. J. Piper, D. R. Harder, W. B. Campbell, R. J. Roman, A. A. Spector et al., Pharmacology of leukotrienes Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function, Br. Med. Bull. J. Vasc. Res. Prog. Lipid Res, vol.39, issue.43, pp.255-259, 1983.

C. R. Pace-asciak, Hepoxilins: a review on their cellular actions, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1215, issue.1-2, pp.1-8, 1994.
DOI : 10.1016/0005-2760(94)90087-6

R. G. Salomon, Distinguishing levuglandins produced through the cyclooxygenase and isoprostane pathways, Chemistry and Physics of Lipids, vol.134, issue.1, pp.1-20, 2005.
DOI : 10.1016/j.chemphyslip.2004.12.003

C. N. Serhan and B. Samuelsson, Lipoxins: A New Series of Eicosanoids (Biosynthesis, Stereochemistry, and Biological Activities), Adv. Exp. Med. Biol, vol.229, pp.1-14, 1988.
DOI : 10.1007/978-1-4757-0937-7_1

M. Björkholm and H. E. Claesson, Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells, Proc. Natl. Acad. Sci. U S A, vol.105, pp.680-685, 2008.

S. Gupta, M. R. Maurya, D. L. Stephens, E. A. Dennis, and S. Subramaniam, An Integrated Model of Eicosanoid Metabolism and Signaling Based on Lipidomics Flux Analysis, Biophysical Journal, vol.96, issue.11, pp.4542-4551, 2009.
DOI : 10.1016/j.bpj.2009.03.011

P. C. Norris and E. A. Dennis, Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling, Proc. Natl. Acad. Sci. (USA) 2012, pp.8517-8522
DOI : 10.1073/pnas.1200189109

A. Leaf and P. C. Weber, Cardiovascular Effects of n-3 Fatty Acids, New England Journal of Medicine, vol.318, issue.9, pp.549-557, 1988.
DOI : 10.1056/NEJM198803033180905

P. Needleman, H. Sprecher, M. O. Whitaker, and A. Wyche, Mechanism underlying the inhibition of platelet aggregation by eicosapentaenoic acid and its metabolites, Adv. Prostaglandin Thromboxane Res, vol.6, pp.61-68, 1980.

D. Boukhchache and M. Lagarde, Interactions between prostaglandin precursors during their oxygenation by human platelets, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.713, issue.2, pp.386-392, 1982.
DOI : 10.1016/0005-2760(82)90257-0

M. Lagarde, B. Drouot, M. Guichardant, and M. Dechavanne, In vitro incorporation and metabolism of some icosaenoic acids in platelets

P. Needleman, M. Minkes, and A. Raz, Thromboxanes: selective biosynthesis and distinct biological properties, Science, vol.193, issue.4248, pp.163-165, 1976.
DOI : 10.1126/science.945611

S. Moncada and J. R. Vane, The role of prostacyclin in vascular tissue, Fed. Proc, vol.38, pp.66-71, 1979.

P. C. Calder, Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale, Biochimie, vol.91, issue.6
DOI : 10.1016/j.biochi.2009.01.008

S. P. Tull, C. M. Yates, B. H. Maskrey, V. B. O-'donnell, J. Madden et al., Omega-3 Fatty Acids and Inflammation: Novel Interactions Reveal a New Step in Neutrophil Recruitment, PLoS Biology, vol.45, issue.8, 2009.
DOI : 10.1371/journal.pbio.1000177.t003

M. O. Whitaker, A. Wyche, F. Fitzpatrick, H. Sprecher, and P. Needleman, Triene prostaglandins: Prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances, Proc. Natl. Acad
DOI : 10.1073/pnas.76.11.5919

E. Tjonahen, S. F. Oh, J. Siegelman, S. Elangovan, K. B. Percarpio et al., Resolvin E2: Identification and Anti-Inflammatory Actions: Pivotal Role of Human 5-Lipoxygenase in Resolvin E Series Biosynthesis, Chemistry & Biology, vol.13, issue.11, pp.1193-1202, 2006.
DOI : 10.1016/j.chembiol.2006.09.011

Y. Isobe, M. Arita, S. Matsueda, R. Iwamoto, T. Fujihara et al., Identification and structure determination of novel antiinflammatory mediator resolvin E3, J. Biol. Chem, vol.17, issue.287, pp.18-10525, 2012.

J. Lefils-lacourtablaise, M. Socorro, A. Géloën, P. Daira, C. Debard et al., 15-Deoxy-12,14-prostaglandin J3: a novel eicosapentaenoic acid-derived prostaglandin that increases adiponectin secretion by adipocytes partly via a PPAR?-dependent mechanism, PLoS One, vol.29, p.63997, 2013.

G. H. Rao, E. Radha, and J. G. White, Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function, Biochemical and Biophysical Research Communications, vol.117, issue.2, pp.549-555, 1983.
DOI : 10.1016/0006-291X(83)91235-4

M. I. Aveldaño and H. Sprecher, Synthesis of hydroxy fatty acids from 4, 7, 10, 13, 16, 19-[1-14C] docosahexaenoic acid by human platelets, J. Biol. Chem, vol.258, pp.9339-9343, 1983.

A. Ariel, P. L. Li, W. Wang, W. X. Tang, G. Fredman et al., The Docosatriene Protectin D1 Is Produced by TH2 Skewing and Promotes Human T Cell Apoptosis via Lipid Raft Clustering, Journal of Biological Chemistry, vol.280, issue.52, pp.43079-43086, 2005.
DOI : 10.1074/jbc.M509796200

P. K. Mukherjee, V. L. Marcheselli, C. N. Serhan, and N. G. Bazan, From The Cover: Neuroprotectin D1: A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress, Proc. Natl. Acad. Sci. U S A, pp.8491-8496, 2004.
DOI : 10.1073/pnas.0402531101

P. Chen, B. Fenet, S. Michaud, N. Tomczyk, E. Véricel et al., Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation, FEBS Letters, vol.94, issue.21, pp.3478-3484, 2009.
DOI : 10.1016/j.febslet.2009.10.004

URL : https://hal.archives-ouvertes.fr/inserm-00429322

C. N. Serhan, R. Yang, K. Martinod, K. Kasuga, P. S. Pillai et al., Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions, The Journal of Experimental Medicine, vol.192, issue.1
DOI : 10.1016/S0076-6879(07)32012-0

J. Clària, J. Dalli, S. Yacoubian, F. Gao, and C. N. Serhan, Resolvin D1 and Resolvin D2 Govern Local Inflammatory Tone in Obese Fat, The Journal of Immunology, vol.189, issue.5, pp.2597-2605, 2012.
DOI : 10.4049/jimmunol.1201272

P. Chen, E. Véricel, M. Lagarde, and M. Guichardant, Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation, The FASEB Journal, vol.25, issue.1, pp.382-388, 2011.
DOI : 10.1096/fj.10-161836

URL : https://hal.archives-ouvertes.fr/inserm-00517396

K. Yamamoto, T. Itoh, D. Abe, M. Shimizu, T. Kanda et al., Identification of putative metabolites of docosahexaenoic acid as potent PPAR?? agonists and antidiabetic agents, Bioorganic & Medicinal Chemistry Letters, vol.15, issue.3, pp.517-522, 2005.
DOI : 10.1016/j.bmcl.2004.11.053

M. Lagarde, A. Gharib, and M. Dechavanne, Different utilization of arachidonic and dihomogammalinolenic acids by human platelet prostaglandin synthetase, Biochimie, vol.59, issue.11-12, pp.935-937, 1977.
DOI : 10.1016/S0300-9084(78)80710-X

R. W. Colman and W. R. Figures, Characteristics of an ADP receptor mediating platelet activation, Molecular and Cellular Biochemistry, vol.59, issue.1-2
DOI : 10.1007/BF00231307

D. Minno, G. Silver, M. J. De-gaetano, and G. , Prostaglandins as Inhibitors of Human Platelet Aggregation, British Journal of Haematology, vol.37, issue.4, pp.637-647, 1979.
DOI : 10.1016/0090-6980(78)90216-2

L. D. Tobias, F. M. Vane, and J. R. Paulsrud, The biosynthesis of 1a, 1b-dihomo-PGF2 and 1a,1bdihomo-PGF2 alpha from 7, 10, 13, 16-docosatetraenoic acid by an acetone-pentane powder of sheep vesicular gland microsomes, Prostaglandins, vol.10, pp.443-468, 1975.

M. M. Milks and . H. Sprecher, 16-docosapentaenoic acid by human platelet cyclooxygenase and lipoxygenase, Biochim. Biophys. Acta, vol.71013, issue.835, pp.29-35, 1985.

P. Homayoun, G. Durand, G. Pascal, and J. M. Bourre, Alteration in Fatty Acid Composition of Adult Rat Brain Capillaries and Choroid Plexus Induced by a Diet Deficient in n-3 Fatty Acids: Slow Recovery After Substitution with a Nondeficient Diet, Journal of Neurochemistry, vol.20, issue.2, pp.45-48, 1988.
DOI : 10.1021/bi00649a026

M. Guichardant and M. Lagarde, Studies on platelet lipoxygenase specificity towards icosapolyenoic and docosapolyenoic acids, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.836, issue.2, pp.210-214, 1985.
DOI : 10.1016/0005-2760(85)90068-2

W. O. Lundberg, The Significance of cis, cis, cis 5,8,11 Eicosatrienoic Acid in Essential Fatty Acid Deficiency, Nutrition Reviews, vol.38, issue.7, pp.233-235, 1980.
DOI : 10.1111/j.1753-4887.1980.tb05910.x

B. A. Jakschik, A. R. Morrison, and H. Sprecher, Products derived from 511-eicosatrienoic acid by the 5-lipoxygenase-leukotriene pathway, J. Biol. Chem, vol.8, issue.258, pp.12797-12800, 1983.

S. Hammarström, Conversion of 511-eicosatrienoic acid to leukotrienes C3 and D3, J. Biol, vol.8

M. Lagarde, M. Burtin, M. Rigaud, H. Sprecher, M. Dechavanne et al., -9 platelet lipoxygenase end-product, FEBS Letters, vol.236, issue.1, pp.53-56, 1985.
DOI : 10.1016/0014-5793(85)81112-1

URL : https://hal.archives-ouvertes.fr/tel-00655887

M. Hamberg, Steric analysis of hydroperoxides formed by lipoxygenase oxygenation of linoleic acid, Analytical Biochemistry, vol.43, issue.2, pp.515-526, 1971.
DOI : 10.1016/0003-2697(71)90282-X

M. R. Buchanan, T. A. Haas, M. Lagarde, and M. Guichardant, 13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX, J. Biol. Chem, vol.260, pp.16056-16059, 1985.

T. L. Kaduce, P. H. Figard, R. Leifur, and A. A. Spector, Formation of 9-hydroxyoctadecadienoic acid from linoleic acid in endothelial cells, J. Biol. Chem, vol.264, pp.6823-6830, 1989.

M. Liu, P. Chen, E. Véricel, M. Lelli, L. Béguin et al., Full characterization and biological effects of new dihydroxylated compounds deriving from alphalinolenic acid, J. Lipid Res, pp.10-1194, 2013.

T. Boussetta, M. Liu, K. Makni, F. Driss, J. El-benna et al., Antiinflammatory effects of protectin DX through inhibition of NADPH oxidase and cyclooxygenase activities

O. Laneuville, D. K. Breuer, N. Xu, Z. H. Huang, D. A. Gage et al., Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)-octadecatrienoic acids from alphalinolenicacid, J. Biol. Chem, vol.270, pp.19330-19336, 1995.

H. Kühn, J. Belkner, R. Wiesner, and L. Alder, Occurrence of 9- and 13-keto-octadecadienoic acid in biological membranes oxygenated by the reticulocyte lipoxygenase, Archives of Biochemistry and Biophysics, vol.279, issue.2, pp.218-224, 1990.
DOI : 10.1016/0003-9861(90)90484-G

B. Fruteau-de-laclos and P. Borgeat, Conditions for the formation of the oxo derivatives of arachidonic acid from platelet 12-lipoxygenase and soybean 15-lipoxygenase, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.958, issue.3, pp.424-433, 1988.
DOI : 10.1016/0005-2760(88)90228-7

P. Patel, C. Cossette, J. R. Anumolu, S. Gravel, A. Lesimple et al., Structural Requirements for Activation of the 5-Oxo-6E,8Z, 11Z,14Z-eicosatetraenoic Acid (5-Oxo-ETE) Receptor: Identification of a Mead Acid Metabolite with Potent Agonist Activity, Journal of Pharmacology and Experimental Therapeutics, vol.325, issue.2
DOI : 10.1124/jpet.107.134908

C. Schneider and A. R. Brash, Lipoxygenase-catalyzed formation of R-configuration hydroperoxides, Prostaglandins & Other Lipid Mediators, vol.68, issue.69
DOI : 10.1016/S0090-6980(02)00041-2

M. Guichardant, S. Bacot, P. Molière, and M. Lagarde, Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites, Prostaglandins Other Lipid Mediat, pp.68-69, 2002.
DOI : 10.1016/j.plefa.2006.05.006

A. Catalá, Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions, Chemistry and Physics of Lipids, vol.157, issue.1, pp.1-11, 2009.
DOI : 10.1016/j.chemphyslip.2008.09.004

I. Amunom, L. J. Stephens, V. Tamasi, J. Cai, W. Pierce et al., Cytochromes P450 catalyze oxidation of ??,??-unsaturated aldehydes, Archives of Biochemistry and Biophysics, vol.464, issue.2, pp.187-196, 2007.
DOI : 10.1016/j.abb.2007.05.019

L. J. Roberts, J. D. Morrow, and . Isoprostanes, Isoprostanes., Annals of the New York Academy of Sciences, vol.327, issue.1 Cellular Gene, pp.237-242, 1994.
DOI : 10.1016/0168-8278(90)90123-9

M. Vanrollins, R. L. Woltjer, H. Yin, J. D. Morrow, and T. J. Montine, F2-Dihomo-isoprostanes arise from free radical attack on adrenic acid, The Journal of Lipid Research, vol.49, issue.5, pp.995-1005, 2008.
DOI : 10.1194/jlr.M700503-JLR200

T. Durand, V. Bultel-poncé, A. Guy, S. Berger, M. J. Mueller et al., New Bioactive Oxylipins Formed by Non-Enzymatic Free-Radical-Catalyzed Pathways: the Phytoprostanes, Lipids, vol.73, issue.10, pp.875-888, 2009.
DOI : 10.1007/s11745-009-3351-1

S. Basu, Isoprostanes, Free Radic. Res, vol.38, pp.105-122, 2004.
DOI : 10.1533/9780857097934.265

S. S. Davies, V. Amarnath, and L. J. Roberts, Isoketals: highly reactive ??-ketoaldehydes formed from the H2-isoprostane pathway, Chemistry and Physics of Lipids, vol.128, issue.1-2, pp.85-99, 2004.
DOI : 10.1016/j.chemphyslip.2003.10.007

C. J. Brame, O. Boutaud, S. S. Davies, T. Yang, J. A. Oates et al., Modification of Proteins by Isoketal-containing Oxidized Phospholipids, Journal of Biological Chemistry, vol.279, issue.14, pp.13447-13451, 2004.
DOI : 10.1074/jbc.M313349200

N. Bernoud-hubac, S. S. Davies, O. Boutaud, T. J. Montine, and L. J. Roberts, Formation of Highly Reactive gamma -Ketoaldehydes (Neuroketals) as Products of the Neuroprostane Pathway, Journal of Biological Chemistry, vol.276, issue.33
DOI : 10.1074/jbc.M103768200

R. Mechoulam, E. Fride, D. Marzo, and V. Endocannabinoids, Endocannabinoids, European Journal of Pharmacology, vol.359, issue.1, pp.1-18, 1998.
DOI : 10.1016/S0014-2999(98)00649-9

D. F. Woodward, Y. Liang, and A. H. Krauss, Prostamides (prostaglandin-ethanolamides) and their pharmacology, British Journal of Pharmacology, vol.272, issue.3, pp.410-419, 2008.
DOI : 10.1038/sj.bjp.0707434

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241799

C. A. Rouzer and L. J. Marnett, Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways, Chemical Reviews, vol.111, issue.10
DOI : 10.1021/cr2002799

T. Bisogno, I. Delton-vandenbroucke, A. Milone, M. Lagarde, D. Marzo et al., Biosynthesis and Inactivation of N-Arachidonoylethanolamine (Anandamide) and N-Docosahexaenoylethanolamine in Bovine Retina, Archives of Biochemistry and Biophysics, vol.370, issue.2, pp.300-307, 1999.
DOI : 10.1006/abbi.1999.1410

H. Y. Kim, A. A. Spector, and Z. M. Xiong, A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development, Prostaglandins & Other Lipid Mediators, vol.96, issue.1-4, pp.114-120, 2011.
DOI : 10.1016/j.prostaglandins.2011.07.002

M. Lagarde, N. Bernoud-hubac, and M. Guichardant, Expanding the horizons of lipidomics, Chemistry and Physics of Lipids, vol.164
DOI : 10.1016/j.chemphyslip.2011.05.071

L. Lagarde and M. , Stable isotope tracer and gas-chromatography combustion isotope ratio mass spectrometry to study the in vivo compartmental metabolism of docosahexaenoic acid, Anal